Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anticoagulation in Patients With COVID-19
Michael E. Farkouh, Gregg W. Stone, Anuradha Lala, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 9, pp. 917-928
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 382
Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19
Gregg W. Stone, Michael E. Farkouh, Anuradha Lala, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 18, pp. 1747-1762
Open Access | Times Cited: 49
S1-Leitlinie Long-/Post-COVID
Andreas Rembert Koczulla, Tobias Ankermann, Uta Behrends, et al.
Pneumologie (2022) Vol. 76, Iss. 12, pp. 855-907
Open Access | Times Cited: 64
Pathophysiological mechanisms of thrombosis in acute and long COVID-19
Haijiao Jing, Xiaoming Wu, Mengqi Xiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis
Nicola Potere, Evan C. Garrad, Yogendra Kanthi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 11, pp. 2046-2060
Open Access | Times Cited: 30
COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 10
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment
Luis Ortega‐Paz, Azita H. Talasaz, Parham Sadeghipour, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 08, pp. 816-832
Open Access | Times Cited: 28
In Situ Pulmonary Arterial Thrombosis: Literature Review and Clinical Significance of a Distinct Entity
Latika Baranga, SIMRANDEEP KHANUJA, Jinel Scott, et al.
American Journal of Roentgenology (2023) Vol. 221, Iss. 1, pp. 57-68
Open Access | Times Cited: 17
Clinical implications of COVID-19 in chronic kidney disease and end-stage kidney disease
Paul Cockwell, Matthew D. Griffin
Elsevier eBooks (2025), pp. 543-568
Closed Access
Single-cell transcriptome-wide Mendelian randomization and colocalization reveals immune-mediated regulatory mechanisms and drug targets for COVID-19
Ying Hui, Xueyan Wu, Xiaojing Jia, et al.
EBioMedicine (2025) Vol. 113, pp. 105596-105596
Open Access
Therapeutic Versus Non‐Therapeutic Dose Anticoagulation in COVID‐19 Infection: A Systematic Review and Meta‐analysis of Randomised Controlled Trials
Sushil Selvarajan, Jisha Sara John, Prathap Tharyan, et al.
eJHaem (2025) Vol. 6, Iss. 1
Open Access
Acute Occlusion of a Persistent Sciatic Artery in a Patient with COVID-19 Infection
Daisuke Futagami, Taira Kobayashi, Hironobu Morimoto, et al.
Annals of Vascular Diseases (2025) Vol. 18, Iss. 1, pp. n/a-n/a
Open Access
Pathogenic mechanisms of cardiovascular damage in COVID-19
Honghua Shao, Rui‐Xing Yin
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 3
Sequelae of long COVID, known and unknown: A review of updated information
Tetsuya Asakawa, Qingxian Cai, Jiayin Shen, et al.
BioScience Trends (2023) Vol. 17, Iss. 2, pp. 85-116
Open Access | Times Cited: 9
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial
Connie N. Hess, Judith Hsia, Ian A. Carroll, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 8, pp. 1572-1582
Open Access | Times Cited: 9
Cardiovascular complications of COVID-19 severe acute respiratory syndrome.
Robert J. Henning
PubMed (2022) Vol. 12, Iss. 4, pp. 170-191
Closed Access | Times Cited: 13
Serum from COVID-19 patients promotes endothelial cell dysfunction through protease-activated receptor 2
Francesco Vieceli Dalla Sega, Francesca Fortini, Danilo Licastro, et al.
Inflammation Research (2023) Vol. 73, Iss. 1, pp. 117-130
Closed Access | Times Cited: 6
Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production
Emily Córneo, Flávio P. Veras, Giovanni Freitas Gomes, et al.
Clinical Immunology (2023) Vol. 257, pp. 109836-109836
Closed Access | Times Cited: 5
The impacts of prophylactic anticoagulation therapy during hospitalization on long-term cardiovascular outcomes in high-risk COVID-19 patients amid the omicron wave of the pandemic
Jun Gu, Yue Wang, Junfeng Zhang, et al.
IJC Heart & Vasculature (2024) Vol. 50, pp. 101353-101353
Open Access | Times Cited: 1
Prevalence of acute neurological complications and pathological neuroimaging findings in critically ill COVID-19 patients with and without VV-ECMO treatment
Angelo Ippolito, Hans Urban, Kimia Ghoroghi, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
COVID-19 Patients With Pulmonary Hypertension Hospitalized in the United States During the Early Pandemic: Analysis of In-Hospital Mortality, Clinical Outcomes, and Racial Disparities
Harris Majeed, Harmon R. Cannon, Kavin Raj, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 11, pp. 101933-101933
Closed Access | Times Cited: 4
Therapeutic-Dose vs. Prophylactic-Dose Anticoagulation Therapy for Critically Ill Patients With COVID-19 in a Practice-Based Observational Study
Yugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Circulation Journal (2022) Vol. 86, Iss. 7, pp. 1137-1142
Open Access | Times Cited: 6
COVID-19 thromboprophylaxis. New evidence
Raquel Ferrandis, P. Sierra, A. Gómez‐Luque
Revista Española de Anestesiología y Reanimación (English Edition) (2023) Vol. 71, Iss. 1, pp. 34-47
Closed Access | Times Cited: 3
Ischemic stroke and intracranial hemorrhage in extracorporeal membrane oxygenation for COVID-19: A systematic review and meta-analysis
Yu Jin, Yang Zhang, Jinping Liu
Perfusion (2022) Vol. 38, Iss. 8, pp. 1722-1733
Open Access | Times Cited: 5
High-Dose Prophylactic Anticoagulation for COVID-19 Pneumonia: A Review of Benefits and Risks
Yeshu Kattakola, Roshan Prasad, Ranjana Sharma, et al.
Cureus (2023)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top